Sharjah: The Gulf Pharmaceutical Industries (Julphar), one of the largest pharmaceutical companies in the Middle East and Africa, announced that its products will become available again in the Sultanate after the successful inspection conducted by the Gulf Health Council (GHC) for Julphar’s manufacturing facilities.
Sheikh Saqr bin Humaid al-Qasimi, Board Chairman of Julphar, said that the company will bring more than 80 registered products to the Sultanate, praising the support provided by the GHC and their continuous guidance to implement more improvements in manufacturing processes.
© Muscat Media Group Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
